U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06864884) titled 'A Phase 1 Study of ARC-001 in Participants Undergoing Third Molar Extraction' on Feb. 26.
Brief Summary: The study will test the investigational product gel against placebo (which contains no active ingredient) to determine if it is safe after wisdom tooth extraction. The main questions the study will answer are:
1. How much of the investigational product is absorbed in the blood?
2. Are there side effects?
Study Start Date: Feb. 26
Study Type: INTERVENTIONAL
Condition:
Acute Post Operative Pain
Third Molar Extraction Surgery
Intervention:
DRUG: ARC-001
Gel formulation containing investigational anesthetic.
Recruitment Sta...